S&P/ASX 200 Pre Market News
Owen Raszkiewicz
August 1, 2018
Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and
SomnoMed Limited (ASX:SOM) today reported it achieved 30% revenue growth
The Aussie sharemarket or ALL ORDINARIES (INDEXASX:XAO)(ASX:XAO) index closed higher
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Australia’s ALL ORDINARIES (INDEXASX:XAO)(ASX:XAO) index closed higher on Tuesday, lifted
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Shares of the leading Australian biotechnology company ResMed Inc. (CHESS)
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
